Tiziana's foralumab continues to be safe and well-tolerated, with no drug-related serious side effects after long-term use, ...

MS is currently treated with 'disease-modifying' medicines (e.g. interferon beta, glatiramer acetate, natalizumab, fingolimod, alemtuzumab, teriflunomide, and dimethyl fumarate). These medicines can ...

Less than two weeks after rejecting Sanofi’s investigational multiple sclerosis drug, the FDA has publicly shared the ...

—To clarify the role that stigma plays in the mental health and quality of life in people with MS, researchers conducted an MS-specific retrospective data review. They found that stigma was associated ...

Explore the significant impact of obesity on multiple sclerosis (MS) progression, including increased symptoms, disability, and comorbidities. Learn how to manage weight effectively with professional ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

As the multiple sclerosis (MS) population ages, managing the condition can bring new challenges. For one woman, working closely with her doctor, exploring treatment options, and finding the right ...

Ocrelizumab is one of three B-cell therapies approved by the FDA to treat MS. This medicine sticks to B cells and keeps them from causing damage. It has the approval to treat: Clinically isolated ...

Multiple sclerosis is an autoimmune disease that currently affects as many as one million Americans, according to the National Multiple Sclerosis Society. A new study has revealed how a compound found ...

Some research suggests that people with multiple sclerosis are at a higher risk of atherosclerosis. An increased risk hasn’t been established, and we don’t know how MS might increase the risk. Having ...